Literature DB >> 9587834

Branch retinal vein occlusion and macroaneurysms.

M B Parodi1, S Da Pozzo, S Saviano, G Ravalico.   

Abstract

BACKGROUND: Macroaneurysms can represent common consequences of branch retinal vein occlusion (BRVO). The aim of the present study is to evaluate the clinical and angiographic aspects of 31 cases of branch retinal vein occlusions (BRVO) in which retinal macroaneurysms developed, in an attempt to analyze their pathogenic features.
METHODS: One hundred and sixty-one consecutive patients affected by BRVO were considered. Each patient underwent an opthalmological examination including fluorescein angiography, at an average interval of two months (range: 1-4 months) from the onset of the disease, with a mean follow-up of 43 months (range: 32-56 months). The macroaneurysms were subdivided according to size into small (from 100 to 149 microns), medium (from 150 to 249 microns), and large (greater than 250 microns), and according to origin into arterial, venous, capillary and collateral-associated.
RESULTS: Thirty-one patients (19.3%) developed retinal macroaneurysms. The total number of detected macroaneurysms was 51; ten (19.6%) were large, 21 (41.2%) were of medium-size and 20 (39.2%) were small in dimension. Three lesions were of arterial origin, 22 were capillary and 26 were from collateral vessels. In 27 patients (87.1%) the lesions were located outside the macular region, and in 4 patients (12.9%) in the macular region. Patients with retinal macroaneurysms did not show a different prevalence of capillary non-perfusion when compared with others. With regard to the number of retinal venous collaterals patients with macroaneurysms developed fewer than other patients, and the difference was statistically significant (p < 0.001).
CONCLUSION: The insufficient number of retinal venous collaterals can be considered the most contributory factor in the development of macroaneurysms secondary to BRVO.

Entities:  

Mesh:

Year:  1997        PMID: 9587834     DOI: 10.1023/a:1026420707368

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  6 in total

1.  Argon laser photocoagulation for macular edema in branch vein occlusion. The Branch Vein Occlusion Study Group.

Authors: 
Journal:  Am J Ophthalmol       Date:  1984-09-15       Impact factor: 5.258

2.  Large capillary aneurysms secondary to retinal venous obstruction.

Authors:  J Schulman; L M Jampol; M F Goldberg
Journal:  Br J Ophthalmol       Date:  1981-01       Impact factor: 4.638

3.  Macroaneurysms associated with retinal branch vein occlusion.

Authors:  S W Cousins; H W Flynn; J G Clarkson
Journal:  Am J Ophthalmol       Date:  1990-05-15       Impact factor: 5.258

4.  Capillary macroaneurysms in central retinal vein occlusion.

Authors:  M Battaglia Parodi; E Bondel; G Ravalico
Journal:  Ophthalmologica       Date:  1995       Impact factor: 3.250

5.  Venous macroaneurysm associated with branch retinal vein obstruction.

Authors:  G E Sanborn; L E Magargal
Journal:  Ann Ophthalmol       Date:  1984-05

6.  Branch retinal vein occlusion and exudative retinal detachment: pathogenetical aspects.

Authors:  M Battaglia Parodi; V Isola
Journal:  Ophthalmologica       Date:  1994       Impact factor: 3.250

  6 in total
  2 in total

1.  Imaging of macroaneurysms occurring during retinal vein occlusion and diabetic retinopathy by indocyanine green angiography and high resolution optical coherence tomography.

Authors:  Alexandre Bourhis; Jean-François Girmens; Severin Boni; Florence Pecha; Catherine Favard; José-Alain Sahel; Michel Paques
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-25       Impact factor: 3.117

2.  Long-Term Follow-Up Case of Multiple Retinal Arterial Macroaneurysms Developing Branch Retinal Vein Occlusion following Ruptured Macroaneurysm.

Authors:  Yuya Terubayashi; Teruyo Kida; Masanori Fukumoto; Jun Sugasawa; Seita Morishita; Hiroyuki Suzuki; Tsunehiko Ikeda
Journal:  Case Rep Ophthalmol       Date:  2016-05-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.